Acute hematogenous osteomyelitis and septic arthritis in children

J Microbiol Immunol Infect. 2003 Dec;36(4):260-5.

Abstract

This retrospective study analyzed the clinical, bacteriological, and radiological features of pediatric patients with acute hematogenous osteomyelitis and septic arthritis. Eighty-four patients with septic arthritis and 39 with acute hematogenous osteomyelitis were enrolled. Their age ranged from 13 days to 17 years. In patients with septic arthritis, the hip joint was the most often infected site. The tibia was the most often involved site in acute hematogenous osteomyelitis. A bacteriological diagnosis was established in 78 (63%) patients. Overall, methicillin-susceptible Staphylococcus aureus (36 cases) was the most common causative organism identified, followed by methicillin-resistant S. aureus (10 cases). The median duration of antibiotic therapy was 33 days. Serum bactericidal titers were obtained for 19 (15%) of the 123 patients. The median duration of hospitalization and antibiotic treatment was not significantly different between patients with and without serum bactericidal titer testing. More patients without serum bactericidal titer testing had symptom relapse which required re-admission for further treatment. In conclusion, the incidence of methicillin-resistant S. aureus as a cause of bone and joint infections has been increasing. Serum bactericidal titer is valuable for the management of patients receiving sequential therapy for acute hematogenous osteomyelitis and septic arthritis.

Publication types

  • Comparative Study

MeSH terms

  • Acute Disease
  • Adolescent
  • Anti-Bacterial Agents / therapeutic use
  • Arthritis, Infectious / immunology
  • Arthritis, Infectious / microbiology*
  • Arthritis, Infectious / therapy
  • Bacterial Infections / immunology
  • Bacterial Infections / microbiology*
  • Bacterial Infections / therapy
  • Blood Bactericidal Activity
  • Child
  • Child, Preschool
  • Female
  • Hip Joint* / microbiology
  • Humans
  • Infant
  • Infant, Newborn
  • Knee Joint* / microbiology
  • Male
  • Methicillin / therapeutic use
  • Methicillin Resistance
  • Osteomyelitis / immunology
  • Osteomyelitis / microbiology*
  • Osteomyelitis / therapy
  • Retrospective Studies
  • Tibia* / microbiology
  • Tibia* / pathology

Substances

  • Anti-Bacterial Agents
  • Methicillin